secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001493152-24-038139
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix enters new employment agreements with CEO and CFO through Aug 2025
-------------------------------------------------------------------------------

- CEO Brian Murphy new agreement: $321K base salary, up to $100K annual bonus, effective Sept 20, 2024 to Aug 31, 2025.
- CFO Stephen Brown new agreement: $267.5K base salary, up to $50K annual bonus, same term as CEO.
- Both agreements allow termination on 90 days notice; severance of 12 months base plus ancillary payments if terminated without cause or for good reason.
- CEO and CFO eligible for future stock option grants under a new equity incentive plan to be adopted.
- Existing 2022 employment agreements were terminated upon effectiveness of new agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224038139/0001493152-24-038139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224038139/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer